SCH 43478

has potent & selective activity against herpesvirus type 2; structure given in first source

Also Known As:

SCH-43478

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Infections 08/01/1997 - "Following subcutaneous administration in a therapeutic treatment regimen, SCH 43478 (90 mg/kg/day) is efficacious in reducing the number and severity of lesions and the neurological complications of acute HSV infection. " 08/01/1997 - "SCH 43478 demonstrates statistically significant efficacy (P < 0.05) in the guinea pig genital model of HSV infection. "